These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 15215544)
1. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544 [TBL] [Abstract][Full Text] [Related]
6. Relationship between lesion size and signal enhancement on subtraction fat-suppressed MR imaging of the breast. Cheung HS; Tse GM; Lai SY; Yeung DK Magn Reson Imaging; 2004 Nov; 22(9):1259-64. PubMed ID: 15607097 [TBL] [Abstract][Full Text] [Related]
7. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging. Low RN; Sigeti JS AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889 [TBL] [Abstract][Full Text] [Related]
8. Small renal masses: assessment of lesion characterization and vascularity on dynamic contrast-enhanced MR imaging with fat suppression. Scialpi M; Di Maggio A; Midiri M; Loperfido A; Angelelli G; Rotondo A AJR Am J Roentgenol; 2000 Sep; 175(3):751-7. PubMed ID: 10954462 [TBL] [Abstract][Full Text] [Related]
9. Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer. Chandarana H; Rosenkrantz AB; Mussi TC; Kim S; Ahmad AA; Raj SD; McMenamy J; Melamed J; Babb JS; Kiefer B; Kiraly AP Radiology; 2012 Dec; 265(3):790-8. PubMed ID: 23175544 [TBL] [Abstract][Full Text] [Related]
10. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions. Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720 [TBL] [Abstract][Full Text] [Related]
12. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging. Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584 [TBL] [Abstract][Full Text] [Related]
13. T2-weighted MR imaging in the assessment of cirrhotic liver. Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306 [TBL] [Abstract][Full Text] [Related]
14. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging. Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572 [TBL] [Abstract][Full Text] [Related]
15. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas. Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457 [TBL] [Abstract][Full Text] [Related]